Recent Finacing
Recent Raise
Enthera is a Milan-based biotech developing monoclonal antibodies and fusion proteins targeting the IGFBP3/TMEM219 pathway; lead program Ent001 aims to restore beta cells and intestinal structure in T1D/IBD.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Enthera.
